Objective To evaluate the efficacy and safety of Elvitegravir,Cobicistat,Emtricit-abine and Tenofovir Alafenamide Fumarate Tablets in initial treatment of acquired immune deficiency syndrome(AIDS)patients.Methods A total of 80 treatment-naive AIDS patients were selected as research subjects and randomly divided into control group and observation group,with 40 patients in each group.The control group was treated with free antiviral drugs(tenofovir+lamivudine+efa-virenz),while the observation group was treated with Elvitegravir,Cobicistat,Emtricitabine and Teno-fovir Alafenamide Fumarate Tablets.The CD4+count,human immunodeficiency virus(HIV)viral load,and biochemical indicators were compared between the two groups before treatment and at 3,6,9,and 12 months after treatment.The adherence,adverse reactions,and quality of life were also com-pared between the two groups.Results During the treatment,six patients in the observation group and 9 patients in the control group had no compliance.With the extension of treatment time,the CD4+level in both groups gradually increased,and the HIV viral load gradually decreased(P＜0.05).After 3,6,9,and 12 months of treatment,the CD4+levels in the observation group were higher than those in the control group,and the HIV viral loads were lower than those in the control group(P＜0.05).With the extension of treatment time,the levels of alanine aminotransferase,aspartate aminotransferase,urea,creatinine,and uric acid in the control group gradually increased,and the random blood glucose levels after 3,6,9,and 12 months of treatment in the control group were higher than those before treatment(P＜0.05).After 3,6,9,and 12 months of treatment,the lev-els of alanine aminotransferase,aspartate aminotransferase,urea,creatinine,uric acid,and random blood glucose in the observation group were lower than those in the control group(P＜0.05).The incidence of adverse reactions in the observation group was 2.94％(1/34),which was lower than 90.00％(36/40)in the control group(correctedx2=55.718,P＜0.001).With the extension of treatment time,the scores of various dimensions of quality of life in both groups gradually increased,and the scores of various dimensions of quality of life after treatment in the observation group were higher than those in the control group(P＜0.05).Conclusion Compared with the free antiviral drug regimen,Elvitegravir,Cobicistat,Emtricitabine and Tenofovir Alafenamide Fumarate Tablets shows better efficacy in the treatment of AIDS-naive patients,which can significantly increase the CD4+level,and reduce the HIV viral load.Besides,it has high safety,and can significantly im-prove their quality of life.

Objective To evaluate the efficacy and safety of Elvitegravir,Cobicistat,Emtricit-abine and Tenofovir Alafenamide Fumarate Tablets in initial treatment of acquired immune deficiency syndrome(AIDS)patients.Methods A total of 80 treatment-naive AIDS patients were selected as research subjects and randomly divided into control group and observation group,with 40 patients in each group.The control group was treated with free antiviral drugs(tenofovir+lamivudine+efa-virenz),while the observation group was treated with Elvitegravir,Cobicistat,Emtricitabine and Teno-fovir Alafenamide Fumarate Tablets.The CD4+count,human immunodeficiency virus(HIV)viral load,and biochemical indicators were compared between the two groups before treatment and at 3,6,9,and 12 months after treatment.The adherence,adverse reactions,and quality of life were also com-pared between the two groups.Results During the treatment,six patients in the observation group and 9 patients in the control group had no compliance.With the extension of treatment time,the CD4+level in both groups gradually increased,and the HIV viral load gradually decreased(P＜0.05).After 3,6,9,and 12 months of treatment,the CD4+levels in the observation group were higher than those in the control group,and the HIV viral loads were lower than those in the control group(P＜0.05).With the extension of treatment time,the levels of alanine aminotransferase,aspartate aminotransferase,urea,creatinine,and uric acid in the control group gradually increased,and the random blood glucose levels after 3,6,9,and 12 months of treatment in the control group were higher than those before treatment(P＜0.05).After 3,6,9,and 12 months of treatment,the lev-els of alanine aminotransferase,aspartate aminotransferase,urea,creatinine,uric acid,and random blood glucose in the observation group were lower than those in the control group(P＜0.05).The incidence of adverse reactions in the observation group was 2.94％(1/34),which was lower than 90.00％(36/40)in the control group(correctedx2=55.718,P＜0.001).With the extension of treatment time,the scores of various dimensions of quality of life in both groups gradually increased,and the scores of various dimensions of quality of life after treatment in the observation group were higher than those in the control group(P＜0.05).Conclusion Compared with the free antiviral drug regimen,Elvitegravir,Cobicistat,Emtricitabine and Tenofovir Alafenamide Fumarate Tablets shows better efficacy in the treatment of AIDS-naive patients,which can significantly increase the CD4+level,and reduce the HIV viral load.Besides,it has high safety,and can significantly im-prove their quality of life.

Objective:To analyze the clinical data of laryngeal airway diseases in infants and provide reference for the standardized diagnosis and treatment of the disease. Methods:From June 2022 to August 2023, analyze the clinical data of 4 cases of children with laryngeal airway diseases recently admitted to Department of Otolaryngology, Fuzhou Children's Hospital of Fujian Province, and summarize the experience and lessons of diagnosis and treatment by consulting relevant literature. Results:Three cases had symptoms such as laryngeal wheezing, dyspnea, backward growth and development, etc. After electronic laryngoscopy, the first case was diagnosed with laryngeal softening （severe, type Ⅱ）, and the angular incision was performed. While cases 2, 3 diagnosed with case 2 and 3 were diagnosed with laryngeal cyst and underwent laryngeal cyst resection. All three cases underwent low-temperature plasma surgery under visual laryngoscope, and the symptoms were relieved after operation. Case 4 was laryngeal wheezing and dyspnea after extubation under general anesthesia. The electronic laryngoscopy showeded early stage of globetic stenosis, and endoscopic pseudomembrane clamping was performed, and the postoperative symptoms were relieved. Conclusion:Infants and young children with laryngeal airway diseases should pay attention to the early symptoms and be diagnosed by electronic laryngoscopy as soon as possible. With good curative effect and few complications, low-temperature plasma surgery under visual laryngoscope is recommended. The formation of pseudomembrane under the gluteal caused by tracheal intubation causes rapid onset and rapid development. The pseudomembrane extraction by clamping is convenient and fast, with good curative effect.
Infant ; Child ; Humans ; Child, Preschool ; Respiratory Sounds/etiology* ; Larynx ; Laryngeal Diseases/surgery* ; Laryngoscopy ; Intubation, Intratracheal/adverse effects* ; Dyspnea/surgery* ; Cysts/surgery*